What is the Ad26.COV2.S coronavirus disease 2019 (COVID-19) vaccine?
Ad26.COV2.S COVID-19 vaccine is derived from viral vector method of technology. It is an adenovirus serotype 26. Dose series = 1 dose Vaccine efficacy = 85.9% Safety concerns = none